Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.99 USD | -1.44% | -7.63% | -44.67% |
25/04 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
25/04 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.67% | 73Cr | |
+5.33% | 11TCr | |
+12.11% | 11TCr | |
-12.56% | 2.23TCr | |
-3.70% | 2.19TCr | |
-6.03% | 1.86TCr | |
-35.21% | 1.81TCr | |
-10.86% | 1.7TCr | |
+5.10% | 1.37TCr | |
+37.57% | 1.24TCr |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.
- Transcript : Sage Therapeutics, Inc., Q1 2023 Earnings Call, May 02, 2023